Kinnate Biopharma Competitors and Similar CompaniesClear all
Kinnate Biopharma's competitors and similar companies include TriSalus Life Sciences, Pharmstandard, Turning Point Therapeutics and AbelZeta.
 Kinnate Biopharma Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. |  TriSalus Life Sciences TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors. |  Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. |  AbelZeta AbelZeta (formerly known as Cellular Biomedicine Group) is a biopharmaceutical company that develops therapeutic solutions. | |
Founding Date | Founding Date 2018 | Founding Date 2009 | Founding Date 2003 | Founding Date 2013 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Westminster, US HQ Bannockburn, US Cranston, US | Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU | Locations San Diego, US HQ | Locations Rockville, US HQ Shanghai, CN |
Employees | Employees 2757% decrease | Employees 106 | Employees 1,77814% increase | Employees 474% decrease | Employees 1261% decrease |
Valuation ($) | Valuation ($) 125 m | Valuation ($) 117.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $45.2m (FY, 2025) | Revenue (est.) ₽152.1b (FY, 2024) | Revenue (est.) $30.8m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $7m (FY, 2025) | Cost of goods ₽117b (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $38.2m (FY, 2025) | Gross profit ₽35.2b (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($112.6m) (FY, 2023) | Net income ($39.2m) (FY, 2025) | Net income ₽22.7b (FY, 2024) | Net income ($236.6m) (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 172.5m | Total funding raised $ 52.2m | Total funding raised N/A | Total funding raised $ 144.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
TriSalus Life Sciences
HQ
Westminster, US
Employees
106
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
View companyPharmstandard
HQ
Dolgoprudny, RU
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
View companyTurning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View companyAbelZeta
HQ
Rockville, US
Employees
126↓ 1% decrease
AbelZeta (formerly known as Cellular Biomedicine Group) is a biopharmaceutical company that develops therapeutic solutions.
View company